Plasma Homocysteine is Associated with Retinopathy in Type 1 Diabetic Patients in the Absence of Nephropathy

References

• Soedamah-Muthu SS, Chaturvedi N, Teerlink T, et al. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: A cross-sectional nested case-control study. J Intern Med 2005;258:450–459
   PubMed Web of Science ®Google Scholar
• Wotherspoon F, Laight DW, Shaw KM, Cummings MH. Homocysteine, endothelial dysfunction and oxidative stress in type 1 diabetes mellitus. Br J Diabetes Vasc Dis 2003;3:334–340
   Google Scholar
• Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomocysteinemia and endothelial dysfunction in IDDM. Diabetes Care 1998;21:841–848
   PubMed Web of Science ®Google Scholar
• Vaccaro O, Perna AF, Mancini FP, et al. Plasma homocysteine and microvascular complications in type 1 diabetes. Nutr Metab Cardiovasc Dis 2000;10:297–304
   PubMed Web of Science ®Google Scholar
• Agardh E, Hultberg B, Agardh CD. Severe retinopathy in type 1 diabetic patients is not related to the level of plasma homocysteine. Scand J Clin Lab Invest 2000;60:169–174
   PubMed Web of Science ®Google Scholar
• Saeed BO, Nixon SJ, White AJ, et al. Fasting homocysteine levels in adults with type 1 diabetes and retinopathy. Clin Chim Acta 2004;341:27–32
   PubMed Web of Science ®Google Scholar
• Neugebauer S, Tarnow L, Stehouwer C, et al. Total plasma homocysteine is associated with hypertension in type 1 diabetic patients. Diabetologia 2002;45:1315–1324
   PubMed Web of Science ®Google Scholar
• Buysschaert M, Jamart J, Dramais AS, et al. Micro- and macrovascular complications and hyperhomocysteinaemia in type 1 diabetic patients. Diabetes Metab 2001;27:655–659
   PubMed Web of Science ®Google Scholar
• Veldman BAJ, Vervoort G, Blom H, Smits P. Reduced plasma total homocysteine concentrations in type 1 diabetes mellitus is determined by increased renal clearance. Diabet Med 2005;22:301–305
   PubMed Web of Science ®Google Scholar
• Chen YF, Li PL, Zou AP. Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function. Circulation 2002;106:1275–1281
   PubMed Web of Science ®Google Scholar
• Chico A, Perez A, Cordoba A, et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: A new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998;41:684–693
   PubMed Web of Science ®Google Scholar
• Pavia C, Ferrer I, Valls C, et al. Total homocysteine in patients with type 1 diabetes. Diabetes Care 2000; 23:84–87
   PubMed Web of Science ®Google Scholar
• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124–136
   PubMed Web of Science ®Google Scholar
• Grunwald JE, Alexander J, Ying GS, et al. Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol 2012;130:1136–1144
   PubMed Web of Science ®Google Scholar
• Brazionis L, Rowley K, Itsiopoulos C, et al. Homocysteine and diabetic retinopathy. Diabetes Care 2008;31:50–56
   PubMed Web of Science ®Google Scholar
• Cho HC. The relationship among homocysteine, bilirubin, and diabetic retinopathy. Diabetes Metab J 2011;35:595–601
   PubMedGoogle Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–612
   PubMed Web of Science ®Google Scholar
• Vučić LM, Radišić BV, Božičević S, et al. Estimating glomerular filtration rate (GFR) in diabetes: The performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria. Clin Biochem 2012;45:1694–1696
   PubMed Web of Science ®Google Scholar
• Aldington SJ, Kohner EM, Meuer S, et al. Methodology for retinal photography and assessment of diabetic retinopathy: The EURODIAB IDDM Complications Study. Diabetologia 1995;38:437–444
   PubMed Web of Science ®Google Scholar
• Hankey GJ, Eikelboom JW, Ho WK, van Bockxmeer FM. Clinical usefulness of plasma homocysteine in vascular disease. Med J Aust 2004;181:314–318
   PubMed Web of Science ®Google Scholar
• Lahiri KD, Dutta J, Datta H, Das HN. Hyperhomocysteinemia, as an independent risk factor for retinal venous occlusion in an Indian population. Indian J Clin Biochem 2013;28:61–64
   PubMedGoogle Scholar
• Sarici AM, Yetik H, Akar S, Arvas S. The association between serum homocysteine levels and retinopathy of prematurity. J Int Med Res 2012;40:1912–1918
   PubMed Web of Science ®Google Scholar
• Gopinath B, Flood VM, Rochtchina E, et al. Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration. Am J Clin Nutr 2013;98:129–135
   PubMed Web of Science ®Google Scholar
• Aydin E, Demir HD, Ozyurt H, Etikan I. Association of plasma homocysteine and macular edema in type 2 diabetes mellitus. Eur J Ophthalmol 2008;18:226–232
   PubMed Web of Science ®Google Scholar
• Lim CP, Loo AV, Khaw KW, et al. Plasma, aqueous and vitreous homocysteine levels in proliferative diabetic retinopathy. Br J Ophthalmol 2012;96:704–707
   PubMed Web of Science ®Google Scholar
• Omae T, Nagaoka T, Tanano I, Yoshida A. Homocysteine inhibition of endothelium-dependent nitric oxide-mediated dilation of porcine retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci 2013;54:2288–2295
   PubMed Web of Science ®Google Scholar
• Chow K, Cheung F, Lao TT, O K. Effect of homocysteine on the production of nitric oxide in endothelial cells. Clin Exp Pharmacol Physiol 1999;26:817–818
   PubMed Web of Science ®Google Scholar
• Bellamy MF, McDowell IF, Ramsey MW, et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998;98:1848–1852
   PubMed Web of Science ®Google Scholar
• Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 2005;6:27–36
   PubMed Web of Science ®Google Scholar
• Maeda M, Fujio Y, Azuma J. MTHFR gene polymorphism and diabetic retinopathy. Curr Diabetes Rev 2006;2:467–476
   PubMedGoogle Scholar
• Poddar R, Sivasubramanian N, DiBello PM, et al. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells. Circulation 2001;103:2717–2723
   PubMed Web of Science ®Google Scholar
• Berg K, Malinow MR, Kierulf P, Upson B. Population variation and genetic of plasma homocyst(e)ine level. Clin Genet 1992;41:315–321
   PubMed Web of Science ®Google Scholar
• Hoffman MA, Kohl B, Zumbach MS, et al. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 1998;21:841–848
   PubMed Web of Science ®Google Scholar
• Norlund L, Grubb A, Fex G, et al. The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 1998;36:175–178
   PubMed Web of Science ®Google Scholar
• Macisaac RJ, Premaratne E, Jerums G. Estimating glomerular filtration rate in diabetes using serum cystatin C. Clin Biochem Rev 2011;32:61–67
   PubMedGoogle Scholar
• Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chem Acta 2003;338:87–90
   PubMed Web of Science ®Google Scholar
• Wollesen F, Brattstrom L, Refsum H, et al. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 1999;55:1028–1035
   PubMed Web of Science ®Google Scholar
• Ubbink JB. Vitamin nutrition status and homocysteine: An atherogenic risk factor. Nutr Rev 1994;52:383–393
   PubMed Web of Science ®Google Scholar
• Kaye J, Stanton K, McCann V, Vasikaran S. Homocysteine, folate, MTHFR genotype and vascular morbidity in diabetic subjects. Clin Sci 2002;102:631–637
   PubMed Web of Science ®Google Scholar
• Shcherbak N, Shutsleaya Z, Sheridina A, et al. MTHFR gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients. Mol Genet Metab 1999;68:375–378
   PubMed Web of Science ®Google Scholar
• Ukinc K, Ersoz HO, Karahan C, et al. Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine 2009;36:255–261
   PubMed Web of Science ®Google Scholar
• McGimpsey SJ, Woodside JV, Cardwell C, et al. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: A meta-analysis. Ophthalmology 2009;116:1778–1787
   PubMed Web of Science ®Google Scholar
• Rowley KG, Lee AJ, Yarmirr D, O’Dea K. Homocysteine concentrations lowered following dietary intervention in an aboriginal community. Asia Pac J Clin Nutr 2003;12:92–95
   PubMed Web of Science ®Google Scholar
• Smolek MK, Notaroberto NF, Jaramillo AG, Pradillo LR. Intervention with vitamins in patients with nonproliferative diabetic retinopathy: A pilot study. Clin Ophthalmol 2013;7:1451–1458
   PubMedGoogle Scholar